In 2018, our research demonstrated that APOM can promote the proliferation and invasion of non-small cell lung cancer cells, which is related to the upregulation of S1P-receptor 1 and activation of the ERK1/2 and PI3K/AKT signalling pathways induced by APOM12. The gene discussed is MAPK3; the disease is non-small cell lung carcinoma.